Journal article
Safety and Tolerability of Pau d’ Arco (Tabebuia avellanedae) for Primary Dysmenorrhea: A Single-Arm, Open-Label Trial on Adults Ages 18-45
Advances in integrative medicine, Vol.9(3), pp.159-166
09/2022
Metrics
8 Record Views
UN Sustainable Development Goals (SDGs)
This output has contributed to the advancement of the following goals:
Source: InCites
Abstract
The aim of this study is to evaluate the safety and tolerability of encapsulated Tabebuia avellanedae in generally healthy women aged 18–45 with primary dysmenorrhea.
Details
- Title
- Safety and Tolerability of Pau d’ Arco (Tabebuia avellanedae) for Primary Dysmenorrhea: A Single-Arm, Open-Label Trial on Adults Ages 18-45
- Creators
- C K McClure - National University of Natural MedicineM Bollen - National University of Natural MedicineL Buttolph - National University of Natural MedicineE Stack - National University of Natural MedicineB O Langley - National University of Natural MedicineD Hanes - National University of Natural MedicineK M Wright - Oregon Health & Science UniversityD Tibbitts - National University of Natural MedicineR Bradley - National University of Natural Medicine
- Publication Details
- Advances in integrative medicine, Vol.9(3), pp.159-166
- Publisher
- Elsevier Ltd
- Grant note
- The funding for this study was provided through the Anna MacIntosh Junior Investigator Research Fellowship funded by the Naturopathic Physicians Licensing Examinations (NPLEX) and this research was supported by grant # K24AT011568 from the National Center for Complementary and Integrative Health of the National Institutes of Health.
- Identifiers
- 991013035752302368
- Academic Unit
- National Centre for Naturopathic Medicine
- Language
- English
- Resource Type
- Journal article